title: Elafin and secretory leukocyte protease inhibitor stimulate the production of cytokines and chemokines by human keratinocytes via MAPK/ERK and NF-κB activation.
authors.forename: Gyi
authors.initials: G
authors.lastname: Aung
authors.forename: François
authors.initials: F
authors.lastname: Niyonsaba
authors.forename: Hiroko
authors.initials: H
authors.lastname: Ushio
authors.forename: Shigaku
authors.initials: S
authors.lastname: Ikeda
authors.forename: Ko
authors.initials: K
authors.lastname: Okumura
authors.forename: Hideoki
authors.initials: H
authors.lastname: Ogawa
mesh_terms: D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis*; D053492:Elafin / Q000378:metabolism* / Q000494:pharmacology; D005786:Gene Expression Regulation; D006801:Humans; D015603:Keratinocytes / Q000187:drug effects / Q000378:metabolism*; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism*; D016328:NF-kappa B / Q000378:metabolism*; D053481:Secretory Leukocyte Peptidase Inhibitor / Q000378:metabolism* / Q000494:pharmacology
chemical_list: D016207:Cytokines; D053492:Elafin; D016328:NF-kappa B; D053481:Secretory Leukocyte Peptidase Inhibitor; D020928:Mitogen-Activated Protein Kinases